- Home
- ALTG vs LCTX Comparison
ALTG vs LCTX Comparison
Compare ALTG & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- LCTX
- Stock Information
- Founded
- ALTG 1984
- LCTX 1990
- Country
- ALTG United States
- LCTX United States
- Employees
- ALTG N/A
- LCTX N/A
- Industry
- ALTG Industrial Machinery/Components
- LCTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALTG Industrials
- LCTX Health Care
- Exchange
- ALTG Nasdaq
- LCTX Nasdaq
- Market Cap
- ALTG 119.3M
- LCTX 107.3M
- IPO Year
- ALTG N/A
- LCTX N/A
- Fundamental
- Price
- ALTG $6.78
- LCTX $0.92
- Analyst Decision
- ALTG Buy
- LCTX Strong Buy
- Analyst Count
- ALTG 3
- LCTX 5
- Target Price
- ALTG $11.67
- LCTX $4.20
- AVG Volume (30 Days)
- ALTG 274.4K
- LCTX 4.5M
- Earning Date
- ALTG 08-06-2025
- LCTX 08-07-2025
- Dividend Yield
- ALTG 3.41%
- LCTX N/A
- EPS Growth
- ALTG N/A
- LCTX N/A
- EPS
- ALTG N/A
- LCTX N/A
- Revenue
- ALTG $1,858,000,000.00
- LCTX $9,557,000.00
- Revenue This Year
- ALTG $1.89
- LCTX N/A
- Revenue Next Year
- ALTG $3.09
- LCTX $232.66
- P/E Ratio
- ALTG N/A
- LCTX N/A
- Revenue Growth
- ALTG N/A
- LCTX 19.42
- 52 Week Low
- ALTG $3.54
- LCTX $0.37
- 52 Week High
- ALTG $11.39
- LCTX $1.15
- Technical
- Relative Strength Index (RSI)
- ALTG 62.78
- LCTX 59.77
- Support Level
- ALTG $6.16
- LCTX $0.87
- Resistance Level
- ALTG $6.57
- LCTX $1.15
- Average True Range (ATR)
- ALTG 0.29
- LCTX 0.11
- MACD
- ALTG -0.01
- LCTX -0.00
- Stochastic Oscillator
- ALTG 72.00
- LCTX 47.98
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.